Copyright: Public domain / Dates by Range: 2000 and later - Digital Collections - National Library of Medicine Search Results

Start Over Copyright Public domain ✖ Dates by Range 2000 and later ✖

1341. COVID-19: federal efforts accelerate vaccine and therapeutic development, but more transparency needed on emergency use authorizations : report to Congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, November 2020
Subject(s):: COVID-19 Vaccines
Drug Approval
Drug Development
Disclosure
United States
United States. Department of Defense
United States. Department of Health and Human Services

1342. Drug development: FDA's priority review voucher programs : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, January 2020
Subject(s):: Drug Approval -- organization & administration
Drug Development -- organization & administration
Rare Diseases -- drug therapy
United States
United States. Food and Drug Administration

1343. Laboratory safety: FDA should strengthen efforts to provide effective oversight : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2020
Subject(s):: Containment of Biohazards -- legislation & jurisprudence
Government Regulation
Laboratories -- legislation & jurisprudence
United States

1344. Indian Health Service: facilities reported expanding services following increases in health insurance coverage and collections : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2019
Subject(s):: Alaskan Natives
American Natives
Insurance Coverage -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
Insurance Coverage -- statistics & numerical data
United States
United States. Indian Health Service
United States.

1345. VA vet centers: evaluations needed of expectations for counselor productivity and centers' staffing : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2020
Subject(s):: Health Workforce
Mental Health Services
Veterans Health Services
United States
United States. Department of Veterans Affairs

1346. Geographic disparities affect access to buprenorphine services for opioid use disorder

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, January 2020
Subject(s):: Buprenorphine -- supply & distribution
Health Services Accessibility
Medically Underserved Area
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States
United States. Department of Health and Human Services
United States. Substance Abuse and Mental Health Services Administration

1347. Indian Health Service has strengthened patient protection policies but must fully integrate them into practice and organizational culture

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2019
Subject(s):: American Natives
Alaskan Natives
Child Abuse, Sexual -- prevention & control
Patients
Sex Offenses -- prevention & control
United States
United States. Department of Health and Human Services
United States. Indian Health Service

1348. Billions in estimated Medicare Advantage payments from chart reviews raise concerns

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2019
Subject(s):: Insurance, Health, Reimbursement
Medical Records -- economics
Medicare Part C -- economics
Quality of Health Care
Risk Adjustment
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

1349. Ownership--but not physical movement--of selected drugs can be traced through the supply chain

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, February 2020
Subject(s):: Prescription Drug Diversion -- prevention & control
Prescription Drugs -- supply & distribution
Counterfeit Drugs -- supply & distribution
United States
United States. Food and Drug Administration

1350. National plan to address Alzheimer's disease: 2020 update

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, [2020]
Subject(s):: Alzheimer Disease -- therapy
Federal Government
Alzheimer Disease -- prevention & control
United States
United States. Department of Health and Human Services

« Previous
Next »
1
2
…
131
132
133
134
135
136
137
138
139
…
246
247